The Search for Quality & Value in Health Care: Implications for Medical Technology - Session II: The Future of Health Care from a Community Perspective
October 5-6, 2004
Indiana University, Indianapolis, IN
American healthcare in crisis: how one community found answers by asking the right questions. On October 5th and 6th, the members of the MTLF and some of the best minds in health system reform met to discover how one American community is collaborating to apply state-of-the-art technology to bring better healthcare value to its citizens. Participants explored ways in which “all healthcare is local” can be translated into a national movement towards healthcare quality and value.
We concluded that the lessons learned in Indiana can be a road map to improvement for other communities and, ultimately, for the entire U.S. healthcare system. In fact, given today’s divisive national political climate and the ponderous weight of federal healthcare policy, true improvements may be more likely to percolate up from local communities than to trickle down from our national government.
Innovative Approaches to the Regulation of Combination Products & New Science: Options for Policymakers
July 29 - 30, 2004
University of California - San Diego
The FDA is constantly challenged to keep pace with scientific discovery and medical innovation. Combination products (tissue engineering, drug-device-biologic combinations) as well as a pipeline of novel breakthroughs create the need for review and reform of traditional regulatory approaches.
The MTLF convened four regional work groups to consider current and future challenges and to offer recommendations for change. On July 29th and 30th, the MTLF met, as guests of the University of California - San Diego, to share its work with top FDA officials, including Dr. Dan Schultz (CDRH), Dr. Jesse Goodman (CBER), and Mr. Mark Kramer (OCP).
2004 Capitol Forum –The Search for Quality and Value in Healthcare: Implications for Medical Technology
February 11th-12th, 2004
Capitol Hill, Washington, D.C.
From the IOM’s breakthrough reports, "To Err is Human" and "Crossing the Quality Chasm," to recent reports by the National Committee on Quality Assurance (NCQA) and the Agency for Healthcare Research and Quality (AHRQ) on the state of quality in medicine, the new emphasis is on paying for performance " finding and rewarding quality and value.
At the 2004 Capitol Forum, experts representing this "next wave" in payment dialogued with MTLF members on issues of quality and value to discuss how best to evaluate the role of advanced medical technology and the incentives for innovation in the new "quality" environment.
